MENU
RLMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Relmada Therapeutics (RLMD) Ownership - Who owns Relmada Therapeutics?
Profile
Industry
N/A
Address
2222 Ponce de Leon Boulevard
Phone
+1 786 629-1376
Employees
20
Web
https://www.relmada.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.18M
P/E Ratio
N/A
Total Cash
54.12M
Projected Growth
N/A
Total Debt
255.93K
Revenue
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash/Share
1.79
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RLMD
Capitalization
14.2M
P/E Ratio
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash
54.1M
Total Cash/Share
1.79
Total Debt
256K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
47.6M
P/B Ratio
0.30
Cash Flow
N/A
Earnings
-2.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
30.2K
Current Ratio
6.89
Current Revenue Per Employee
682.00
Dividends Per Share - Security
N/A
EBITDA
-91.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
-0.44
Revenue To Assets
-104.91
Shares Held By Institutions
49.6M
Shares Outstanding - Current
30.2M
Total Liabilities
8.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-9.596
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2222 Ponce de Leon Boulevard
Phone
+1 786 629-1376
Employees
20
Web
https://www.relmada.com